越來越多的美國(guó)人用自然療法替代處方藥

越來越多的美國(guó)人用自然療法替代處方藥

Half of Americans have turned to a natural remedy to treat an ailment, rather than a prescription medication, according to new research.

最新調(diào)查顯示，一半的美國(guó)人選擇了自然療法來治療疾病，而不是處方藥。

A survey of 2,000 Americans found one in two of those surveyed have eschewed more traditional medicine in favor of natural alternatives.

一項(xiàng)針對(duì)2000名美國(guó)人的調(diào)查發(fā)現(xiàn)，在接受調(diào)查的美國(guó)人中，有兩分之一的人選擇了天然替代品，而不是傳統(tǒng)藥物。

The study examined respondents’ opinions on natural remedies, cannabis, marijuana and hemp, as well as the recent increase in opioid use in the United States.

該研究調(diào)查了受訪者對(duì)自然療法、dama的看法，以及最近美國(guó)阿片類藥物使用量的增加。

Results found nearly three-quarters of respondents believe natural remedies – such as cannabis, marijuana or hemp – are safer than prescription medicines (74 percent).

結(jié)果發(fā)現(xiàn)，近四分之三的受訪者認(rèn)為天然藥物——如醫(yī)用dama——比處方藥更安全(74%)。

Another 78 percent of respondents believe that cannabis should be more available as a pain treatment – with 52 percent in strong agreement and another 27 percent in slight agreement.

另有78%的受訪者認(rèn)為，dama應(yīng)該更多地用于止痛，52%的受訪者對(duì)此表示強(qiáng)烈贊同，另有27%的受訪者對(duì)此表示輕微贊同。

More than seven in 10 respondents, however, believed there is a negative stigma around using natural remedies for pain relief, including the use of medical cannabis.

然而，超過七成的受訪者認(rèn)為，使用天然藥物緩解疼痛，包括醫(yī)用dama，是一種負(fù)面的恥辱。

Conducted by OnePoll on behalf of Remedy Review, the survey also found 78 percent of respondents reported using a natural remedy at some point.

調(diào)查還發(fā)現(xiàn)，78%的受訪者表示曾使用過天然藥物。

Respondents reported choosing to use a natural remedy because it was more affordable (66 percent) and easier to obtain (56 percent) than a prescription medication.

受訪者表示，選擇使用自然療法是因?yàn)樗忍幏剿幐阋?66%)，也更容易獲得(56%)。

Half of those polled who said they had turned to a natural remedy rather than a prescription also reported feeling worried they would become addicted to prescription medication.

接受調(diào)查的人中有一半表示，他們?cè)笾谧匀化煼?，而不是處方，他們還表示擔(dān)心自己會(huì)對(duì)處方藥上癮。

Respondents were then asked what they felt would be efficient ways to combat the increased use of opioids across the United States – with seven in 10 respondents describing it as a “crisis.”

然后，調(diào)查對(duì)象被問及他們認(rèn)為應(yīng)對(duì)美國(guó)阿片類藥物使用增加的有效方法是什么——十分之七的受訪者稱這是一場(chǎng)“危機(jī)”。

Nearly eight in 10 respondents agreed with the sentiment that doctors should be held legally responsible if they overprescribe opioids and patients become addicted.

近80%的受訪者認(rèn)為，如果醫(yī)生開了過多的阿片類藥物，讓病人上癮，那么他們應(yīng)該承擔(dān)法律責(zé)任。

The top avenue to combat the opioid crisis, according to those surveyed, is increasing regulations for drug companies and manufacturers that make opioids (59 percent).

據(jù)調(diào)查顯示，應(yīng)對(duì)阿片類藥物危機(jī)的首要途徑是加強(qiáng)對(duì)生產(chǎn)阿片類藥物的制藥公司和制造商的監(jiān)管(59%)。

However, 79 percent of respondents also said more research is needed to fully understand the medical properties and benefits of cannabis and marijuana.

然而，79%的受訪者表示，還需要更多的研究來充分了解dama和dama的醫(yī)學(xué)特性和益處。

“Hemp-derived CBD offers people the chance to find relief without fear of addiction,” said Marc Lewis, Executive Editor of Remedy Review. “But with this promise comes a need for more clinical studies, industry oversight and clear quality standards to govern production.”

“dama衍生的CBD給人們提供了一個(gè)不用擔(dān)心上癮就能得到放松的機(jī)會(huì)，”《補(bǔ)救評(píng)論》的執(zhí)行編輯馬克·劉易斯說。“但與此同時(shí)，我們需要更多的臨床研究、行業(yè)監(jiān)管和明確的質(zhì)量標(biāo)準(zhǔn)來規(guī)范生產(chǎn)。”

More people than you think are using products that contain compounds derived from cannabis, however, as 69 percent of respondents reported using a product that contains cannabidoil (CBD) at some point in their lives – with 33 percent currently using one.

然而，使用含有dama化合物的產(chǎn)品的人比你想象的要多，69%的受訪者表示在他們的生活中曾使用過含有大麻二酚(CBD)的產(chǎn)品，33%的人目前正在使用這種產(chǎn)品。

Although CBD is not illegal, 46 percent of respondents incorrectly believed CBD products are fully approved by the Food and Drug Administration.

雖然CBD并不違法，但是46%的受訪者錯(cuò)誤地認(rèn)為CBD產(chǎn)品已經(jīng)完全通過了食品和藥物管理局的審批。

In reality, the FDA has only approved one prescription drug product and has not approved any other CBD products.

事實(shí)上，F(xiàn)DA只批準(zhǔn)了一種處方藥，沒有批準(zhǔn)任何其他CBD產(chǎn)品。